Has Sankaran Krishnan received payments from drug or device companies?

Yes. Drug and device makers reported $1,302 in general payments to Sankaran Krishnan across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sankaran Krishnan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sankaran Krishnan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sankaran Krishnan

Pediatric Pulmonology · Hawthorne, NYNPI 1427058866

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by AstraZeneca at 36.8% of the total.

$1,302in general payments, 2019–2025

Across 14 payments — averaging $93.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$479
Boston Scientific$149
Nevro Corp.$127
Novo Nordisk$125
Amarin Pharma, Inc.$125
Davol Inc.$120
plus $178 from 3 others

$416,501in research payments, 2019–2025

Across 32 payments — averaging $13,016 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AstraZeneca$207K
Astrazeneca UK Limited$102K
Sanofi US Services Inc.$87K
Regeneron$21K

What the payments were for

Food & beverage$1,302100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	4	$479
Boston Scientific	2	$149
Nevro Corp.	1	$127
Novo Nordisk	1	$125
Amarin Pharma, Inc.	1	$125
Davol Inc.	2	$120
Corcept Therapeutics	1	$78
Sanofi	1	$67
Astrazeneca UK Limited	1	$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,302 in reported general payments places this provider in the 75th percentile of 102 pediatric pulmonology providers in New York.

See all pediatric pulmonology providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluticasone Propionate HfaFluticasone Propionate	12	$2,626

Paid to pharmacies, not to this prescriber.

Other pediatric pulmonology in Hawthorne

Nikhil AminHawthorne$4K
John WelterHawthorne$2K
Joseph BoyerHawthorne$2K
Suzette GjonajHawthorne$1K
Christy KimHawthorne$705
Yehudit PollackHawthorne$696
Agnes BanquetHawthorne$256
Elizabeth de la Riva-VelascoHawthorne$226
Youngsook Cathy KimHawthorne$202
Catherine KierStony Brook$176K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →